Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.
MarketWatch.com - Top Stories, MarketWatch
Fri, 06/23/2023 - 4:52pm
Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday.